|
MRSN Mersana Therapeutics Inc 1442836 |
| Balance Sheet |
|
Current Assets
|
136,904,000 |
|
Assets
|
144,663,000 |
|
Current Liabilities
|
62,458,000 |
|
Liabilities
|
154,172,000 |
|
Equity
|
-9,509,000 |
|
Shares Out
|
122,675,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-82,340,000 |
|
Investing Cash Flow
|
11,437,000 |
| Market Analysis |
Market Cap
|
252,097,133 |
|
Price
|
0.44 |
|
BVPS
|
18.77 |
|
PB
|
0.02 |
|
EPS
|
-0.86 |
|
PS
|
1.56 |
|
FCF
|
-70,903,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/28 |
-0.16 |
3/3 |
-0.56 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MRSN documents filed with the SEC.
MRSN Filings
Clear
